← Open Payments lookup

CASEY COWDIN: Open Payments

NPI 1023687126 · MANHATTAN, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$844 in 53 payments from 14 companies in 2025. Trend: 2023 $636 · 2024 $994 · 2025 $844

Food & beverage: $844
CompanyPaymentsAmount
Novo Nordisk Inc15$224
ABBVIE INC.11$177
Amgen Inc.11$137
Lilly USA, LLC4$62
Bayer Healthcare Pharmaceuticals Inc.2$40
Medtronic, Inc.1$37
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$30
Merck Sharp & Dohme LLC1$24
Janssen Pharmaceuticals, Inc1$23
AstraZeneca Pharmaceuticals LP1$22

Products named: VRAYLAR, Rybelsus, OTEZLA, Wegovy, EVENITY, QULIPTA, JARDIANCE, Ozempic.

Industry payments across KS — which companies pay providers there.